GLP-1 Medications & the Dental Patient: Clinical Considerations for Oral Health

Thursday, January 29, 2026

9:00 am – 12:00 pm

Course Code:

411TL

Cost:

$130

Credits:

3

CE Hours

Assistant
Dentist
General Health
Hygienist
Lecture
Office
Technician

In this course, attendees will gain foundational knowledge of GLP-1 receptor agonist medications, including semaglutide, liraglutide, and related therapies, and their growing use in the management of type 2 diabetes and obesity. While direct research on the oral health implications of GLP-1s is currently limited, these medications are reshaping patient health in ways that intersect with dental care. Attendees will examine how GLP-1s affect systemic physiology, including metabolism, nutrition, bone density, and healing, factors with potential downstream relevance for the dental setting. The instructors will discuss observed changes in taste preferences, altered dietary patterns, and weight loss–related shifts that may influence caries risk, periodontal stability, and prosthodontic planning. The course aims to raise awareness, promote interprofessional communication, and equip dental teams to better understand and support patients using these increasingly common therapies.

Speakers

After this course attendees will be able to:

  • Understand the physiology and psychosocial considerations in obesity etiology and management and review dietary/lifestyle interventions for weight loss
  • Describe the role and systemic effects of GLP-1 receptor agonist medications in the management of diabetes and obesity
  • Recognize the indications, contraindications, weight-loss trajectories and advantages and disadvantages of GLP-1 medications
  • Compare weight loss medications with bariatric surgery and diet/lifestyle intervention
  • Explain the barriers and challenges of GLP-1 medications and understand future considerations for these medications
  • Discuss the current state of evidence regarding the relationship between GLP-1 use and oral health outcomes
  • Identify potential considerations for healing, bone metabolism, and periodontal status in patients using GLP-1s
  • Evaluate how significant weight loss and nutritional shifts might impact prosthodontic fit, temporomandibular joint function, and oral musculature
  • Apply relevant knowledge of GLP-1 therapy when planning care and scheduling dental procedures

Thank you to The Friedman School of Nutrition Science and Policy and Tufts School of Dental Medicine for their collaboration on this program.

The Massachusetts Dental Society is an ADA CERP Recognized Provider

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at

ADA.org/CERP